363 related articles for article (PubMed ID: 367136)
1. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
[TBL] [Abstract][Full Text] [Related]
2. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease.
Glancy DL; Richter MA; Ellis EV; Johnson W
Am J Med; 1977 Jan; 62(1):39-46. PubMed ID: 319662
[TBL] [Abstract][Full Text] [Related]
3. Antianginal effect of isosorbide dinitrate spray in patients with exercise-induced stable angina.
Aärynen M; Soininen K
J Int Med Res; 1986; 14(6):303-5. PubMed ID: 3803701
[TBL] [Abstract][Full Text] [Related]
4. Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
Handler CE; Sullivan ID
Int J Cardiol; 1985 Feb; 7(2):149-57. PubMed ID: 3882583
[TBL] [Abstract][Full Text] [Related]
5. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
Thadani U; Fung HL; Darke AC; Parker JO
Am J Cardiol; 1982 Feb; 49(2):411-9. PubMed ID: 7058754
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.
Willis WH; Russell RO; Mantle JA; Ratshin RA; Rackley CE
Chest; 1976 Jan; 69(1):15-22. PubMed ID: 811427
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
8. Effects of amlodipine and isosorbide dinitrate on exercise-induced and ambulatory ischemia in patients with chronic stable angina pectoris.
Steffensen R; Melchior T; Bech J; Nissen H; Haastrup B; Grande P; Rasmussen V; Hansen JF; Skagen K; Haghfelt T
Cardiovasc Drugs Ther; 1997 Nov; 11(5):629-35. PubMed ID: 9493700
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of sustained-action isosorbide dinitrate on exercise-induced myocardial ischemia.
Brunner D; Meshulam N; Zerieker F
Chest; 1974 Sep; 66(3):282-7. PubMed ID: 4607776
[No Abstract] [Full Text] [Related]
11. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.
Liang CS; Coplin B; Wellington K
Am J Cardiol; 1985 May; 55(12):9E-14E. PubMed ID: 4003286
[TBL] [Abstract][Full Text] [Related]
13. Enhanced effectiveness of combined sustained-release forms of isosorbide dinitrate and diltiazem for stable angina pectoris.
Lehmann G; Reiniger G; Haase HU; Rudolph W
Am J Cardiol; 1991 Oct; 68(10):983-90. PubMed ID: 1927938
[TBL] [Abstract][Full Text] [Related]
14. Clinical and circulatory effects of oral isosorbide dinitrate in patients with angina during exercise.
Lauwers PL; Tackels R
Acta Cardiol; 1975; 30(4):293-312. PubMed ID: 1084659
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study.
Ogawa H; Yasue H; Nakamura N; Fujii H; Miyagi H; Kikuta K
Int J Cardiol; 1995 Feb; 48(2):131-7. PubMed ID: 7774991
[TBL] [Abstract][Full Text] [Related]
16. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
Thadani U; Fung HL; Darke AC; Parker JO
Circulation; 1980 Sep; 62(3):491-502. PubMed ID: 7398008
[No Abstract] [Full Text] [Related]
17. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
18. Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.
van de Ven LL; Vermeulen A; Tans JG; Tans AC; Liem KL; Lageweg NC; Lie KI
Int J Cardiol; 1995 Jan; 47(3):217-23. PubMed ID: 7721498
[TBL] [Abstract][Full Text] [Related]
19. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
Parker JO; VanKoughnett KA; Fung HL
Am J Cardiol; 1984 Jul; 54(1):8-13. PubMed ID: 6430057
[TBL] [Abstract][Full Text] [Related]
20. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
Thadani U; Prasad R; Hamilton SF; Voyles WF; Doyle R; Karpow SA; Reder R; Teague SM
Clin Pharmacol Ther; 1987 Jul; 42(1):58-65. PubMed ID: 3595067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
